https://openbell.ai/ 2026-10-08T17:36:28.111Z hourly 1.0 https://openbell.ai/support 2026-10-08T17:36:28.111Z monthly 0.7 https://openbell.ai/privacy 2026-10-08T17:36:28.111Z monthly 0.5 https://openbell.ai/terms 2026-10-08T17:36:28.111Z monthly 0.5 https://openbell.ai/feed.json 2026-10-08T17:36:28.111Z hourly 0.8 https://openbell.ai/news/BAH:1791480876418 2026-10-08T17:34:36.418Z daily 0.9 https://cdn.brandfetch.io/BAH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Upgrades Booz Allen Hamilton to Buy, Raises Price Target to $85 Truist Securities has upgraded Booz Allen Hamilton (NYSE: BAH) from a Hold rating to a Buy rating. The price target for the stock has been raised from $70 to $85. https://openbell.ai/news/LHX:1791480815221 2026-10-08T17:33:35.221Z daily 0.9 https://cdn.brandfetch.io/LHX/w/400/h/400?c=1idopYfmtR7ZKg8QMud NASA Awards L3harris Contract To Build All Glass Telescope For Laser Interferometer Space Antenna Mission NASA has awarded L3Harris Technologies a contract to develop an all-glass telescope for the Laser Interferometer Space Antenna (LISA) mission. This contract is part of NASA's efforts to advance space-based gravitational wave detection technology. The financial details of the contract have not been disclosed, but it represents a significant opportunity for L3Harris in the aerospace sector. https://openbell.ai/news/WMT:1791480759639 2026-10-08T17:32:39.639Z daily 0.9 https://cdn.brandfetch.io/WMT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Walmart Opens Fulfillment Center In Stockton, CA, Creating 1,000+ Jobs Walmart has opened its fifth next-generation fulfillment center in Stockton, California, which spans over 900,000 square feet and is expected to create more than 1,000 jobs. This facility will utilize advanced automation and technology to enhance fulfillment capacity and improve shipping and delivery times for customers on the West Coast. The strategic location in California's Central Valley aims to strengthen Walmart's supply chain and expand faster shipping options for millions of items. https://openbell.ai/news/KO:1791480412465 2026-10-08T17:26:52.465Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Minsk--Belarus--July-13--2023---Electron.jpg?width=250&height=187 PepsiCo Is Handing Market Share to Coca-Cola, Analyst Warns PepsiCo reported a 5.6% increase in quarterly revenue to $25.27 billion, exceeding estimates, but lowered its fiscal 2026 adjusted earnings outlook to $8.34 to $8.43 per share, below analysts' expectations. Analysts warn that PepsiCo is losing beverage market share to Coca-Cola and Keurig Dr Pepper, with PepsiCo's North American carbonated soft drink business underperforming. Coca-Cola's stock rose nearly 2% amid this market shift, and it is scheduled to report third-quarter earnings on October 27, with expectations of earnings of 88 cents per share and revenue of $12.90 billion. https://openbell.ai/news/NVDA:1791480328283 2026-10-08T17:25:28.283Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud NVIDIA shares are trading lower following reports suggesting that OpenAI's annualized revenues are approximately $20 billion less than what was previously communicated, which may lower confidence in AI. openbell Financial News https://openbell.ai/news/CRWD:1791480147042 2026-10-08T17:22:27.042Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Crowdstrike-Sign-And-Logo-At-Headquarter.jpg?width=250&height=187 CrowdStrike Stock Rises Amid Tech Turbulence: What's Going On? CrowdStrike Holdings Inc (NASDAQ: CRWD) saw its stock rise 0.43% to $266.58 following BMO Capital's decision to raise its price target from $235 to $295, reflecting a 25.53% increase. Analyst Keith Bachman maintained an Outperform rating, citing positive insights from investor meetings with the company's leadership regarding sustained growth in enterprise security spending. Management indicated that the increasing complexity of cybersecurity threats and the impact of AI on security budgets will drive higher spending in the sector. https://openbell.ai/news/IMAX:1791480044312 2026-10-08T17:20:44.312Z daily 0.9 https://cdn.brandfetch.io/IMAX/w/400/h/400?c=1idopYfmtR7ZKg8QMud B. Riley Securities Maintains Buy on Imax, Raises Price Target to $64 B. Riley Securities analyst Drew Crum has maintained a 'Buy' rating on Imax (NYSE: IMAX) and increased the price target from $61 to $64. This adjustment reflects a positive outlook for the company's performance. https://openbell.ai/news/META:1791479975122 2026-10-08T17:19:35.122Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud UPDATE: 'Trump Bought Up To $25 Million In Meta And Millions In SpaceX Debt In August' - CNBC Former President Donald Trump purchased up to $25 million in Meta shares and invested millions in SpaceX debt during August 2026. This financial activity was disclosed in his recent financial filings. The investments indicate Trump's continued interest in technology and space sectors. https://openbell.ai/news/XYZ:1791479933389 2026-10-08T17:18:53.389Z daily 0.9 https://cdn.brandfetch.io/XYZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'FTC Probes Block After Consumer Complaints Over Frozen Accounts'- Bloomberg The Federal Trade Commission (FTC) is investigating Block Inc. following consumer complaints regarding frozen accounts. This scrutiny comes amid concerns about the company's account management practices. The investigation could have implications for Block's operations and reputation in the financial services sector. https://openbell.ai/news/CVX:1791479857505 2026-10-08T17:17:37.505Z daily 0.9 https://cdn.brandfetch.io/CVX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of oil and gas-related companies are trading higher amid multiple catalysts including renewed Iranian focus on striking vessels in the Strait of Hormuz, Tehran's hardline stance on nuclear enrichment limits, and Houthi rebel strikes on Saudi Arabia. Also, elevated refined product prices, refining margins, and tanker day rates are benefiting the wider sector. openbell Financial News https://openbell.ai/news/MSFT:1791479667933 2026-10-08T17:14:27.933Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'OpenAI annualised revenues $20bn less than previously signalled' - Financial Times OpenAI's annualized revenues are reported to be $20 billion less than previously indicated. This adjustment may impact Microsoft's investment and partnership strategies, as MSFT has been closely associated with OpenAI. The news could also influence market perceptions of AI-related investments and their growth potential. https://openbell.ai/news/TSM:1791479389682 2026-10-08T17:09:49.682Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/TSMC--Photo-by-Sundry-Photography-on-Shu.jpg?width=250&height=187 EXCLUSIVE: TSMC Plans Up to $64 Billion in Capex and Still Isn’t ‘Building Enough,’ Says Applied Materials Veteran TSMC reported a record third-quarter revenue of NT$1.49 trillion ($46.71 billion), a 50% increase year-over-year, surpassing analysts' expectations. The company has raised its capital expenditure (capex) plan to between $60 billion and $64 billion, with a significant portion allocated to advanced process technology and packaging. Industry veteran Steve Williams expressed concerns that TSMC may not be building enough capacity to meet demand, particularly in advanced packaging, as leading-edge wafer capacity is sold out through 2027. TSM shares declined by 1.7% to $464 following the news. https://openbell.ai/news/MSFT:1791479283158 2026-10-08T17:08:03.158Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'OpenAI annualised revenues $20bn less than previously signalled' - Financial Times OpenAI's annualized revenues are now reported to be $20 billion less than previously indicated. This revision may impact investor sentiment and market expectations regarding the company's financial performance. The news could also have implications for Microsoft (MSFT), which has significant investments in OpenAI. https://openbell.ai/news/BTCUSD:1791479276437 2026-10-08T17:07:56.437Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Cryptocurrency-Coins-Displaying-XRP--Sol.jpg?width=250&height=187 Bitcoin at $81,000, XRP, Dogecoin Plunge 7%: What Is Going On? Bitcoin fell below $81,000, with $489 million liquidated across crypto markets in one hour. The decline was influenced by three main catalysts: the US government moving $1 billion in Bitcoin from a hack seizure wallet, geopolitical tensions regarding potential strikes on Iran, and signals from the Federal Reserve indicating another interest rate hike is expected before year-end. Other cryptocurrencies, including XRP and Dogecoin, also experienced declines of 6% and 7%, respectively. https://openbell.ai/news/KNX:1791479243877 2026-10-08T17:07:23.877Z daily 0.9 https://cdn.brandfetch.io/KNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Stifel Maintains Buy on Knight-Swift, Raises Price Target to $90 Stifel analyst J. Bruce Chan has reiterated a Buy rating on Knight-Swift (NYSE: KNX) and increased the price target from $88 to $90. This adjustment reflects a positive outlook for the company's stock performance. https://openbell.ai/news/MU:1791479225654 2026-10-08T17:07:05.654Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Watching Micron Technology; Hearing Investor Business Daily SwingTrader Sells Stock openbell Financial News https://openbell.ai/news/CG:1791479175857 2026-10-08T17:06:15.857Z daily 0.9 https://cdn.brandfetch.io/CG/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Carlyle Says Deal to Buy Lukoil International Assets Has Expired'- Bloomberg Carlyle Group announced that its agreement to acquire Lukoil's international assets has expired. The expiration of this deal may impact Carlyle's strategic positioning in the energy sector. Further details regarding the financial implications or future plans were not disclosed. https://openbell.ai/news/SPCX:1791479147094 2026-10-08T17:05:47.094Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'SpaceXAI Hit With Biometric Suit Over Images Uploaded to Grok'- BloombergLaw SpaceXAI is facing a biometric lawsuit concerning images that were uploaded to its Grok platform. The suit raises issues related to privacy and the use of biometric data. Details regarding potential financial implications or stock price movements for SpaceXAI (ticker: SPCX) were not provided in the article. https://openbell.ai/news/JZ:1791479141217 2026-10-08T17:05:41.217Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_2.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Thursday's Intraday Session On Thursday, Jianzhi Education Tech (NASDAQ:JZ) saw a significant stock increase of 77.7%, reaching $0.83, with a market value of $1.1 million. Fly-E Group (NASDAQ:FLYE) also experienced a notable rise of 74.4% to $2.21, bringing its market value to $2.0 million. Conversely, GMEX Robotics (NASDAQ:GMEX) faced a sharp decline of 27.8%, dropping to $1.92, with a market cap of $2.0 million. https://openbell.ai/news/PCRX:1791479140964 2026-10-08T17:05:40.964Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Health Care Stocks Moving In Thursday's Intraday Session On Thursday, Pacira BioSciences (NASDAQ:PCRX) saw its shares increase by 44.0% to $36.3, with a market capitalization of $1.0 billion. Other notable gainers included Onconetix (NASDAQ:ONCO), which rose 34.2% to $0.8, and Haemonetics (NYSE:HAE), which increased by 17.58% to $119.6, also holding a market cap of $4.6 billion. Conversely, China SXT Pharmaceuticals (NASDAQ:SXTC) experienced a significant decline of 87.7% to $0.35, resulting in a market cap of $1.5 million. https://openbell.ai/news/IPW:1791479140733 2026-10-08T17:05:40.733Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Industrials Stocks Moving In Thursday's Intraday Session On Thursday, iPower (NASDAQ: IPW) shares rose 19.7% to $1.25, with a market value of $1.3 million following the release of their Q4 earnings. Other notable gainers included Star Equity Holdings (up 16.54% to $10.71) and CDT Environmental Tech (up 14.84% to $1.24). Conversely, VCI Global saw a significant decline of 27.5% to $0.56, while Resources Connection fell 22.2% to $2.91 after their Q1 earnings report. https://openbell.ai/news/AIXI:1791479140525 2026-10-08T17:05:40.525Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Information Technology Stocks Moving In Thursday's Intraday Session On Thursday, XIAO-I (NASDAQ:AIXI) saw a significant increase of 49.2%, reaching $1.97, with a market cap of $17.4 million. Other notable gainers included Biddance AI Systems (NASDAQ:HKIT) up 14.58% to $2.76, and Republic Power Group (NASDAQ:RPGL) rising 14.55% to $41.63. Conversely, Nvni Group (NASDAQ:NVNI) experienced a sharp decline of 33.7%, dropping to $0.57, while Veea (NASDAQ:VEEA) fell 20.81% to $3.73. https://openbell.ai/news/HAE:1791479082607 2026-10-08T17:04:42.607Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Konskie--Poland---April-12--2025-Haemone.jpg?width=250&height=187 Haemonetics Stock Hits 52-Week High - Here's Why Haemonetics Corporation (NYSE: HAE) stock reached a 52-week high, rising 16.02% to $118.00 after CSL Plasma Inc. announced plans to deploy Haemonetics' NexSys PCS devices with Persona PLUS technology across all its U.S. plasma collection centers by the end of 2027. This expansion follows a nonexclusive supply agreement allowing CSL Plasma to utilize Haemonetics' technology. The company maintained its fiscal 2027 financial guidance but will provide further details on the agreement's financial impact during its fiscal second-quarter earnings call in November 2026. https://openbell.ai/news/BYRN:1791478969221 2026-10-08T17:02:49.221Z daily 0.9 https://cdn.brandfetch.io/BYRN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Byrna Technologies shares are trading higher after the company reported Q3 results. The company reportedly cut production costs. openbell Financial News https://openbell.ai/news/SPY:1791478905691 2026-10-08T17:01:45.691Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/SP-500-Set-To-Surge-Like-Never-Before-Be.jpg?width=250&height=187 S&P 500 Hits New Highs Ahead of Four-Year Bull Market Anniversary: Market Expert Says ‘Party Isn’t Over Yet’ The SPDR S&P 500 ETF Trust (NYSE: SPY) reached new all-time highs this week, marking the 27th new high for the S&P 500 in 2026, as the current bull market approaches its four-year anniversary, having started on October 12, 2022. Market expert Ryan Detrick emphasizes that despite various negative headlines, the bull market remains strong, with historical data suggesting that bull markets lasting four years typically continue into their fifth year, averaging an 18.4% gain. Detrick notes that historically, the fourth quarter is the best for stocks, with an 80% success rate and an average gain of 4.2%. https://openbell.ai/news/NVDA:1791478693775 2026-10-08T16:58:13.775Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Trump to Unveil $2.4B in AI Pledges to Boost Research'- Bloomberg Former President Trump is set to announce $2.4 billion in pledges aimed at enhancing artificial intelligence research. This initiative is expected to significantly impact the AI sector, potentially benefiting companies like NVIDIA (NVDA) involved in AI technology. The announcement reflects a broader commitment to advancing AI capabilities in the United States. https://openbell.ai/news/QQQ:1791478557959 2026-10-08T16:55:57.959Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Ray-Dalio-Warns-AI-Will-Create-Unprecede.jpg?width=250&height=187 AI Bubble Nearing a Breaking Point? Ray Dalio’s Warning Reveals a Risk Hiding in These ETFs Ray Dalio, founder of Bridgewater, warned that the AI bubble may be nearing a breaking point, highlighting the risks associated with concentrated investments in major tech stocks like Nvidia, Apple, and Microsoft, which together represent nearly 21% of the S&P 500. The SPDR S&P 500 ETF Trust and Vanguard S&P 500 ETF both show significant exposure to these companies, with Nvidia, Apple, and Microsoft accounting for over 21% of their portfolios. In contrast, the Invesco S&P 500 Equal Weight ETF offers a more balanced approach, potentially mitigating risks associated with heavy reliance on a few mega-cap stocks. https://openbell.ai/news/MSFT:1791478228899 2026-10-08T16:50:28.899Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'OpenAI annualised revenues $20bn less than previously signalled' - Financial Times OpenAI's annualized revenues are now reported to be $20 billion less than previously indicated. This adjustment may impact Microsoft's financial outlook, as the tech giant has significant investments in OpenAI. The revised revenue figures could influence market perceptions and stock performance for Microsoft. https://openbell.ai/news/PCRX:1791478195354 2026-10-08T16:49:55.354Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Merger-And-Acquisition-Business-Corporat.jpg?width=250&height=187 Viatris Bets Big on Non-Opioid Painkillers With Pacira Buyout Viatris Inc. has announced its acquisition of Pacira BioSciences Inc. for $1.65 billion, paying $36.50 per share in cash. This deal aims to enhance Viatris' non-opioid pain management portfolio, adding two established treatments: EXPAREL and ZILRETTA. Following the announcement, Viatris' stock fell nearly 3%, while Pacira's stock surged over 44%. The acquisition is expected to close by the end of 2026 and is anticipated to positively impact Viatris' financial metrics and operational synergies. https://openbell.ai/news/GKOS:1791478177248 2026-10-08T16:49:37.248Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Photo-Of-Implantable-Collamer-Lens.jpg?width=250&height=187 Glaukos Advances Eye Care Portfolio with Three-Year Epioxa Trial Data and Licensing Deal Glaukos Corporation (NYSE: GKOS) reported positive three-year trial results for its Epioxa treatment for keratoconus, demonstrating a 1.9 diopter improvement in maximum corneal curvature and maintaining a clean safety profile. Additionally, the company secured an exclusive licensing agreement with RevOpsis Therapeutics Inc. to develop RO-104, a biologic targeting multiple retinal conditions, while also gaining rights to develop up to four more retinal biologics. Following these announcements, Glaukos shares fell 10.76% to $153.65. https://openbell.ai/news/BIAF:1791478169878 2026-10-08T16:49:29.878Z daily 0.9 https://cdn.brandfetch.io/BIAF/w/400/h/400?c=1idopYfmtR7ZKg8QMud BIAF stock has given up its prior gain. bioAffinity Technologies shares were trading higher after the company announced that the Japan Patent Office issued a Notice of Allowance indicating its intention to grant a patent for the method of predicting the likelihood of lung cancer powered by the CyPath Lung test for early-stage lung cancer. openbell Financial News https://openbell.ai/news/DVN:1791478087211 2026-10-08T16:48:07.211Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Devon-Energy-Corp--NYSE-DVN.jpg?width=250&height=187 Devon Energy Eagle Ford Sale to Boost Buybacks and Reduce Debt Devon Energy Corporation (NYSE: DVN) announced a deal to sell its Eagle Ford assets to Crescent Energy for $4.2 billion in cash, which represents about 4% of its total production. The sale is expected to enhance free cash flow, extend inventory life, and reduce debt, with proceeds allocated for share repurchases. The transaction is set to close around the end of 2026, pending regulatory approvals. Devon's shares rose by 2.07% to $48.87 following the announcement. https://openbell.ai/news/MSFT:1791477903141 2026-10-08T16:45:03.141Z daily 0.9 https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'OpenAI annualised revenues $20bn less than previously signalled' - Financial Times OpenAI's annualized revenues are now reported to be $20 billion less than previously indicated. This adjustment could impact Microsoft's financial outlook, as the tech giant has significant investments in OpenAI. The revised revenue figures may lead to changes in market expectations regarding the performance of both companies. https://openbell.ai/news/XOM:1791477864503 2026-10-08T16:44:24.503Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Channahon--Illinois--Usa--June-7-2022-Ex.jpg?width=250&height=187 What's Going On With ExxonMobil Stock On Thursday? ExxonMobil (NYSE: XOM) shares rose approximately 2% on Thursday, trading at $167.89, following the Trump administration's proposed rollback of methane regulations, which could save oil and gas producers, including ExxonMobil, an estimated $45 billion annually in compliance costs. The global crude benchmarks also increased by over 4% amid ongoing Middle East tensions. Looking ahead, ExxonMobil's earnings report is expected on October 30, 2026, with an estimated EPS of $3.75 and revenue of $102.02 billion, reflecting significant year-over-year growth. https://openbell.ai/news/GFS:1791477817555 2026-10-08T16:43:37.555Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Konskie--Poland---January-22--2024-Globa.jpg?width=250&height=187 GlobalFoundries Lands $2 Billion TSMC Deal to Expand US AI Chip Packaging GlobalFoundries Inc. (NASDAQ: GFS) has entered a $2 billion, five-year manufacturing agreement with Taiwan Semiconductor Manufacturing Co. (NYSE: TSM) to supply U.S.-produced silicon interposers for TSMC's advanced packaging ecosystem. The expansion at GlobalFoundries' Malta, New York facility aims to support high-performance computing and AI workloads, with volume production expected to start in the first half of 2028. Following the announcement, GFS shares rose 4.46% to $50.22. https://openbell.ai/news/WSM:1791477355587 2026-10-08T16:35:55.587Z daily 0.9 https://cdn.brandfetch.io/WSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Live On CNBC, Josh Brown Hosts Segment Titled "Josh's Best Stocks In The Market: Williams-Sonoma" openbell Financial News https://openbell.ai/news/IVN:1791477326456 2026-10-08T16:35:26.456Z daily 0.9 https://cdn.brandfetch.io/IVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Ivanhoe Mines, Raises Price Target to C$16 UBS analyst Daniel Major has maintained a Buy rating on Ivanhoe Mines (TSX: IVN) and increased the price target from C$15 to C$16. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/FUTU:1791476955558 2026-10-08T16:29:15.558Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Los-Angeles--California---July-11-2025-W.jpg?width=250&height=187 Webull Just Exposed a Bigger China Risk for Futu and UP Fintech Webull Corp (NASDAQ: BULL) is under congressional scrutiny for its ties to China, which could impact other companies like Futu Holdings Limited (NASDAQ: FUTU) and UP Fintech Holding Limited (NASDAQ: TIGR). Futu is facing a separate regulatory issue in China with a proposed penalty of approximately $271 million, while UP Fintech has also been penalized for unlicensed operations. Futu reported a 33.6% year-over-year increase in funded accounts and a 35.6% rise in revenue to HK$7.2 billion in Q2, indicating growth driven by international markets. https://openbell.ai/news/HBM:1791476927989 2026-10-08T16:28:47.989Z daily 0.9 https://cdn.brandfetch.io/HBM/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Hudbay Minerals, Raises Price Target to C$46 UBS analyst George Eadie has maintained a 'Buy' rating on Hudbay Minerals (TSX: HBM) and increased the price target from C$43 to C$46. This adjustment reflects a positive outlook for the company in the market. https://openbell.ai/news/BMY:1791476866211 2026-10-08T16:27:46.211Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Rueil-malmaison--France---August-13--202.jpg?width=250&height=187 Bristol Myers Squibb’s Zenbexus Delivers Major Blood Cancer Win, Cuts Progression Risk 51% Bristol Myers Squibb announced positive topline results from its Phase 3 EXCALIBER-RRMM study, showing that its drug Zenbexus (iberdomide) reduced the risk of disease progression or death by 51% in multiple myeloma patients. The study involved 800 individuals and demonstrated a median progression-free survival of 42 months for those treated with Zenbexus, compared to 20 months for the standard treatment. Following these results, Bristol Myers Squibb's stock was down 1.41% to $58.86. https://openbell.ai/news/FM:1791476486637 2026-10-08T16:21:26.637Z daily 0.9 https://cdn.brandfetch.io/FM/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on First Quantum Minerals, Raises Price Target to C$60 UBS has maintained a 'Buy' rating on First Quantum Minerals (TSX: FM) and increased its price target from C$55 to C$60. This adjustment reflects UBS's positive outlook on the company's performance. https://openbell.ai/news/AAPL:1791476025763 2026-10-08T16:13:45.763Z daily 0.9 https://cdn.brandfetch.io/AAPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Bloomberg's Mark Gurman Posts On X "t's official: Apple has sent out invitations for a "Welcome home" product launch on Oct. 13 in New York." Apple has officially sent out invitations for a product launch event titled 'Welcome home' scheduled for October 13 in New York. This announcement was made by Bloomberg's Mark Gurman on X. The event may have implications for AAPL stock as new product launches often influence market performance. https://openbell.ai/news/BHVN:1791475911721 2026-10-08T16:11:51.721Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/08/Richmond--Virginia--Usa---9-May-2019-Ill.jpg?width=250&height=187 Biohaven Expands Asian Licensing Footprint Through Strategic Ono Agreement Biohaven Ltd. (NYSE: BHVN) has entered a licensing agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize its MoDE pan IgG degrader portfolio in Japan, South Korea, Taiwan, and ASEAN countries. The agreement includes an upfront payment of $80 million and potential milestone payments totaling up to $100 million, along with approximately 20% royalties on net sales from licensed products. Biohaven's lead candidate, BHV-1300, is currently in Phase 3 clinical development for Graves' disease. https://openbell.ai/news/BIAF:1791475836762 2026-10-08T16:10:36.762Z daily 0.9 https://cdn.brandfetch.io/BIAF/w/400/h/400?c=1idopYfmtR7ZKg8QMud bioAffinity Technologies Commences ~$4M Offering Of Common Stock At $6.122 Per Share bioAffinity Technologies, Inc. has announced a registered direct offering of common stock, aiming to raise approximately $4 million at a price of $6.122 per share. The proceeds will be used for working capital and to support the expected growth in sales of its noninvasive lung cancer test, CyPath® Lung. The offering is conducted under Nasdaq rules and involves an institutional investor. https://openbell.ai/news/AXTA:1791475735437 2026-10-08T16:08:55.437Z daily 0.9 https://cdn.brandfetch.io/AXTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Conditional EU antitrust approval expected for AkzoNobel, Axalta deal, sources say' - Reuters The European Union is expected to grant conditional antitrust approval for the merger between AkzoNobel and Axalta, according to sources. This approval is a significant step forward for the deal, which aims to enhance AkzoNobel's position in the coatings market. The news may impact Axalta's stock performance, which is currently traded under the ticker AXTA. https://openbell.ai/news/ZBAO:1791475655290 2026-10-08T16:07:35.290Z daily 0.9 https://cdn.brandfetch.io/ZBAO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Zhibao Technology shares are trading lower after the company announced a 1-for-50 reverse stock split. openbell Financial News https://openbell.ai/news/CS:1791475644491 2026-10-08T16:07:24.491Z daily 0.9 https://cdn.brandfetch.io/CS/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Capstone Copper, Raises Price Target to C$18 UBS analyst George Eadie has maintained a Buy rating on Capstone Copper (TSX: CS) and increased the price target from C$17 to C$18. This adjustment reflects a positive outlook for the company's performance. https://openbell.ai/news/BIAF:1791475373951 2026-10-08T16:02:53.951Z daily 0.9 https://cdn.brandfetch.io/BIAF/w/400/h/400?c=1idopYfmtR7ZKg8QMud bioAffinity Technologies shares are trading higher after the company announced that the Japan Patent Office issued a Notice of Allowance indicating its intention to grant a patent for the method of predicting the likelihood of lung cancer powered by the CyPath Lung test for early-stage lung cancer. openbell Financial News https://openbell.ai/news/CVX:1791475319369 2026-10-08T16:01:59.369Z daily 0.9 https://cdn.brandfetch.io/CVX/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Maintains Buy on Chevron, Raises Price Target to $235 UBS analyst Josh Silverstein has reaffirmed a Buy rating on Chevron (NYSE: CVX) and increased the price target from $220 to $235. https://openbell.ai/news/DKI:1791475189661 2026-10-08T15:59:49.661Z daily 0.9 https://cdn.brandfetch.io/DKI/w/400/h/400?c=1idopYfmtR7ZKg8QMud DarkIris shares are trading lower after the company announced the pricing of its $6 million offering of 4,166,666 units. openbell Financial News